Time and Date: 11:00 a.m.5:00 p.m., Eastern Standard Time, Thursday, January 11, 2007.

Place: Audio Conference Call via FTS Conferencing. The USA toll free dial in number is 1.866.643.6504 with a pass code of 9448550.

Status: Open to the public, but without a public comment period.

Background: The Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation ]]> http://thefederalregister.com/d.p/2006-12-28-E6-22380 Thu, Dec 28 2006 11:00:00 GMT http://thefederalregister.com/d.p/2006-12-28-E6-22253 ]]> http://thefederalregister.com/d.p/2006-12-28-E6-22253 Thu, Dec 28 2006 11:00:00 GMT http://thefederalregister.com/d.p/2006-12-28-06-9884

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Director's Consumer Liaison Group.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: National Cancer Institute Director's Consumer Liaison Group.

Date: January 25, 2007.

Time: 1 p.m. 2:30 p.m.

Agenda: (1) Approval Minutes of September 28, 2006 Teleconference and October 25, 2006 inperson meeting; (2) Introduce new Office of Advocacy Relations leadership and Director's charge to the DCLG members (3) Report of DCLG Member Activities; (4) Preparation for the March in person meeting; (5) Public Comment Public Comment; (6) Action Items and Conclusion.
[[Page 7 ]]> http://thefederalregister.com/d.p/2006-12-28-06-9884 Thu, Dec 28 2006 11:00:00 GMT http://thefederalregister.com/d.p/2006-12-28-06-9888

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, February 13, 2007, 8:00 a.m. to February 15, 2007, 5 p.m., Hyatt Regency bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD, 20814 which was published in the Federal Register on November 30, 2006, 71 FR 69211.

The meeting notice is changed to reflect the name of the committee from ``SPORE II'' to ``SPORE in Prostate, Breast and Skin Cancer.'' The meeting is closed to the public.

Dated: December 20, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 069888 Filed 122806; 8:45 am]
BILLING CODE 414001M ]]> http://thefederalregister.com/d.p/2006-12-28-06-9888 Thu, Dec 28 2006 11:00:00 GMT http://thefederalregister.com/d.p/2006-12-28-06-9889

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Mentored Research Scientist Development Award.

Date: January 5, 2007.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).

Con ]]> http://thefederalregister.com/d.p/2006-12-28-06-9889 Thu, Dec 28 2006 11:00:00 GMT http://thefederalregister.com/d.p/2006-12-28-06-9887

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Drug Discovery.

Date: January 3, 2007.

Time: 3 p.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Mary Custer, PhD., Scientific Review Administrator, ]]> http://thefederalregister.com/d.p/2006-12-28-06-9887 Thu, Dec 28 2006 11:00:00 GMT http://thefederalregister.com/d.p/2006-12-28-E6-22187 ]]> http://thefederalregister.com/d.p/2006-12-28-E6-22187 Thu, Dec 28 2006 11:00:00 GMT